B. Park

发表

Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B

Byung Gyu Kim, N. Park, S. Jung, 2017, Digestive Diseases and Sciences.

Putative association of transforming growth factor‐α polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

Ju Sun Kim, J. Bae, Hyoki Kim, 2009, Journal of viral hepatitis.

Mutational analysis of SATB1 gene in hepatocellular carcinomas

N. Park, S. Jung, J. Shin, 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Prediction of response to entecavir therapy in patients with HBeAg‐positive chronic hepatitis B based on on‐treatment HBsAg, HBeAg and HBV DNA levels

B. Kim, N. Park, I. Jeong, 2012, Journal of viral hepatitis.

Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

S. Lee, N. Park, S. Jung, 2020, Digestive Diseases and Sciences.

Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir

S. Lee, N. Park, S. Jung, 2018, The American Journal of Gastroenterology.

Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival.

E. Shin, Y. Chung, N. Park, 2012, Journal of hepatology.

Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir

S. Lee, N. Park, I. Jeong, 2020, Clinical and molecular hepatology.

Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice

N. Park, S. Jung, J. Shin, 2015, International Journal of Clinical Pharmacy.

Clinical course of patients with insufficient viral suppression during entecavir therapy in genotype C chronic hepatitis B.

Byung Gyu Kim, N. Park, I. Jeong, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

HBV Dna Level at 24 Weeks is the Best Predictor of Virological Response to Adefovir Add-On Therapy in Patients with Lamivudine Resistance

Byung Gyu Kim, N. Park, I. Jeong, 2012, Antiviral therapy.

Mitotic checkpoint gene MAD1 in hepatocellular carcinoma is associated with tumor recurrence after surgical resection

N. Park, S. Jung, J. Shin, 2008, Journal of surgical oncology.

Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B

E. Shin, Y. Chung, N. Park, 2014, Hepatology.

Mutational analysis of FEN1 Gene in hepatocellular carcinomas

H. Cha, N. Park, S. Jung, 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

HBV Dna Level at 24 Weeks is the Best Predictor of Virological Response to Adefovir Add-On Therapy in Patients with Lamivudine Resistance

Byung Gyu Kim, N. Park, I. Jeong, 2012, Antiviral therapy.

The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin

N. Park, I. Jeong, S. Jung, 2012, Scandinavian journal of gastroenterology.

Putative association of transforming growth factor‐α polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

Ju Sun Kim, J. Bae, Hyoki Kim, 2009, Journal of viral hepatitis.